5 Results for "

CDK2/CycA2

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "CDK2/CycA2" in MCE Product Catalog:

  • Isoforms Recommended:
  • Targets Recommended:
41
41 Cited Publications
Cat. No.: HY-12214A
CAS No.: 1263373-43-8
Purity:  99.60%
Target:  

CDK Apoptosis

Research Areas:  

Cancer

NVP-2 is a potent and selective ATP-competitive cyclin dependent kinase 9 (CDK9) probe, inhibits CDK9/CycT activity with an IC50 of 0.514 nM. NVP-2 displays inhibitory effcts on CDK1/CycB, CDK2/CycA and CDK16/CycY kinases with IC50 values of 0.584 μM, 0.706 μM, and 0.605 μM, respectively. NVP-2 induces cell apoptosis.
loading...
    loading...
Cat. No.: HY-145694
CAS No.: 2639542-32-6
Purity:  99.49%
Target:  

CDK

Research Areas:  

Others

CDK5-IN-3 (compound 11) is a potent CDK5 inhibitor, with IC50s of 0.6 nM and 18 nM for CDK5/p25 and CDK2/CycA, respectively. CDK5-IN-3 can be used for the research of autosomal dominant polycystic kidney disease (ADPKD) .
loading...
    loading...
Cat. No.: HY-145693
CAS No.: 2639542-22-4
Target:  

CDK

Research Areas:  

Others

CDK5-IN-2 (compound 15) is a highly selective CDK5 inhibitor with IC50s of 0.2 and 23 for CDK5/p25 and CDK2/CycA, respectively .
loading...
    loading...
Cat. No.: HY-E70670
Target:  

CDK

Research Areas:  

Cancer

CDK2 is a cyclin-dependent kinase involved in the control of the cell cycle. CDK2/CycA2 Recombinant Human Active Protein Kinase is an ortholog of CDK2 .
loading...
    loading...
Cat. No.: HY-147698
CAS No.: 2851977-85-8
Research Areas:  

Cancer

ZLHQ-5f is a dual CDK2 and Topo I inhibitor with an IC50 of 0.145 μM against CDK2/CycA2. ZLHQ-5f arrests the cell cycle in S-phase, triggers apoptosis in HCT116 cells, and has a good safety profile .
loading...
    loading...